92 related articles for article (PubMed ID: 33250425)
21. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
Xu WY; Wickizer TM; Jung JK
BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
[TBL] [Abstract][Full Text] [Related]
22. Economic Cost and Sustainability of Oral Therapies in Precision Oncology.
Desai AP; Scheckel CJ; Soderberg LC; Jensen CJ; Orme JJ; Tella SH; Kommalapati A; Pritchett JC; Khera N; Mahipal A; Go RS;
JCO Oncol Pract; 2022 Aug; 18(8):e1247-e1254. PubMed ID: 35617640
[TBL] [Abstract][Full Text] [Related]
23. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
[TBL] [Abstract][Full Text] [Related]
24. Use of eye care and associated charges among the Medicare population: 1991-1998.
Ellwein LB; Urato CJ
Arch Ophthalmol; 2002 Jun; 120(6):804-11. PubMed ID: 12049587
[TBL] [Abstract][Full Text] [Related]
25. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
26. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.
Ito K; Elkin E; Blinder V; Keating N; Choudhry N
Cancer; 2013 Jul; 119(13):2494-502. PubMed ID: 23775433
[TBL] [Abstract][Full Text] [Related]
27. Patterns of Care for Medicare Beneficiaries With Metastatic Prostate Cancer.
Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
[TBL] [Abstract][Full Text] [Related]
28. The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis.
Keating NL; Brooks GA; Landrum MB; Liu PH; Wolf R; Riedel LE; Kapadia NS; Jhatakia S; Tripp A; Simon C; Hsu VD; Kummet CM; Hassol A
J Natl Cancer Inst; 2022 Jun; 114(6):871-877. PubMed ID: 35134972
[TBL] [Abstract][Full Text] [Related]
29. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
[TBL] [Abstract][Full Text] [Related]
30. Screening Mammography Utilization Among Female Medicare Beneficiaries and Breast Cancer Survivors in 2002-2016.
Fahim SM; Huo N; Li C; Qian J
J Womens Health (Larchmt); 2021 May; 30(5):739-749. PubMed ID: 33211608
[No Abstract] [Full Text] [Related]
31. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.
Barnato AE; McClellan MB; Kagay CR; Garber AM
Health Serv Res; 2004 Apr; 39(2):363-75. PubMed ID: 15032959
[TBL] [Abstract][Full Text] [Related]
32. The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans.
Buntin MB; Garber AM; McClellan M; Newhouse JP
Health Serv Res; 2004 Feb; 39(1):111-30. PubMed ID: 14965080
[TBL] [Abstract][Full Text] [Related]
33. Depression treatment and healthcare expenditures among elderly Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancer.
Alwhaibi M; Sambamoorthi U; Madhavan S; Walkup JT
Psychooncology; 2017 Dec; 26(12):2215-2223. PubMed ID: 27891701
[TBL] [Abstract][Full Text] [Related]
34. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.
Dinan MA; Curtis LH; Hammill BG; Patz EF; Abernethy AP; Shea AM; Schulman KA
JAMA; 2010 Apr; 303(16):1625-31. PubMed ID: 20424253
[TBL] [Abstract][Full Text] [Related]
35. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
36. Increased healthcare costs by later stage cancer diagnosis.
McGarvey N; Gitlin M; Fadli E; Chung KC
BMC Health Serv Res; 2022 Sep; 22(1):1155. PubMed ID: 36096813
[TBL] [Abstract][Full Text] [Related]
37. Health Care Utilization and Cost Outcomes of a Comprehensive Dementia Care Program for Medicare Beneficiaries.
Jennings LA; Laffan AM; Schlissel AC; Colligan E; Tan Z; Wenger NS; Reuben DB
JAMA Intern Med; 2019 Feb; 179(2):161-166. PubMed ID: 30575846
[TBL] [Abstract][Full Text] [Related]
38. Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; Krasnow SH; Shulman LN; Brown JR; Earle CC; Oh WK; Rabin M; McNeil BJ
Ann Intern Med; 2011 Jun; 154(11):727-36. PubMed ID: 21646556
[TBL] [Abstract][Full Text] [Related]
39. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.
Lang K; Hao Y; Huang H; Lin I; Rogerio JW; Menzin J
J Comp Eff Res; 2014 Sep; 3(5):481-90. PubMed ID: 25350800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
